The FDA granted AngioDynamics expanded 510(k) clearance for its OARtrac Radiation Dose Monitoring System, a device used to measure photon radiation and high dose rate (HDR) brachytherapy during cancer treatments.

The additional clearance is for use with pre-calibrated, patient-specific peak skin dose sensors that measure photon and electron radiation therapy to supplement a patient’s treatment planning.

The OARtrac system enables clinicians to measure and validate radiation doses targeted at a specific area of the patient’s body, providing more information and accuracy for dosing.